Is serum hyaluronan a helpful tool in the management of patients with liver diseases?

Journal of Internal Medicine

Volumn 242, Issue 1, 1997, Pages 67-71

  Lindqvist, U ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Human; Hyaluronan; Liver disease; Serum

Indexed keywords

CELL RECEPTOR; HYALURONIC ACID; LAMININ; PARACETAMOL;

ALCOHOL LIVER DISEASE; BILE DUCT ATRESIA; BLOOD LEVEL; CONFERENCE PAPER; DISEASE ACTIVITY; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER TRANSPLANTATION; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; VIRUS HEPATITIS;

EID: 0030843455     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00176.x     Document Type: Conference Paper

References (37)

1. Fraser JRE, Laurent TC, Pertoft H, Baxter E. Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 1981; 200: 415-24.
2. Fraser JRE, Alcorn D, Laurent TC, Robinson AD, Ryan GB. Uptake of circulating hyaluronic acid by rat liver. Cellular localization in situ. Cell Tissue Res 1985; 242: 505-10.
3. Smedsrod B, Pertoft H;, Eriksson S, Fraser JRE, Laurent TC. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984; 223: 617-26.
4. Laurent TC, Fraser JRE, Pertoft H, Smedsrød B. Binding of hyaluronate and chondroitin sulphate to liver endothelial cells. Biochem J 1986; 234: 653-8.
5. Alston-Smith J, Pertoft H, Laurent TC. Endocytosis of hyaluronan in rat Kupffer cells. Biochem J 1992; 286: 519-26.
6. Fraser JRE, Laurent TC, Engström-Laurent A, Laurent UBG. Elimination of hyaluronic acid from the blood stream in the human. Clin Exp Pharmacol Physiol 1984; 11: 17-25.
7. Bentsen KD, Henriksen JH, Boesby S, Hørslev-Petersen K, Lorenzen I. Hepatic and renal extraction of circulating type III procollagen amino-terminal propeptide and hyaluronan in pig. J Hepatol 1989; 9: 177-83.
8. Laurent TC, Lilja K, Brunnberg L, Engström-Laurent A, Laurent UBG, Lindqvist U et al. Urinary excretion of hyaluronan in man. Scand J Clin Lab Invest 1987; 47: 793-9.
9. Engström-Laurent A, Laurent UBG, Lilja K, Laurent TC. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985; 45: 497-504.
10. Gressner AM, Haarmann R. Hyaluronic acid synthesis and secretion by rat liver fat storing cells (perisinusoidal lipocytes) in culture. Biochem Biophys Res Commun 1988; 151: 222-9.
11. Alston-Smith J, Pertoft H, Laurent TC, Hyaluronan synthesis by rat liver stellate cells is enhanced under endotoxic conditions. Matrix 1993; 13: 313-22.
12. Lindqvist U, Laurent TC. Serum hyaluronan and aminoterminal propeptide of type III procollagen. Variation with age. Scand J Clin Lab Invest 1992; 52: 613-21.
13. Trivedi P, Cheeseman P, Mowat AP. Serum hyaluronic acid in healthy infants and children and its value as a marker of progressive hepatobiliary disease starting in infancy. Clin Chim Acta 1993; 215: 29-39.
14. Engström-Laurent A, Lööf L, Nyberg A, Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985; 4: 638-42.
15. Frébourg T, Delpech B, Bercoff E, Senate J, Bertrand P, Deugnier Y, Bourreille J. Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology 1986; 6: 392-5.
16. Nyberg A, Engström-Laurent A, Lööf L. Serum hyaluronate in primary biliary cirrhosis - a biochemical marker for progressive liver damage. Hepatology 1988; 8: 142-6.
17. Babbs Ch Haboubi NY, Mellor JM, Smith A, Rowan BP, Warnes TW. Endothelial cell transformation in primary biliary cirrhosis: a morphological and biochemical study. Hepatology 1990; 11: 723-9.
18. Fraser JRE, Engström-Laurent A, Nyberg A, Laurent TC. Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis. J Lab Clin Med 1986; 107: 79-85.
19. Lindqvist U, Groth T, Lööf L, Hellsing K. A hyaluronan-loading test applied to patients with liver and joint diseases. Clin Chem Acta 1992; 210: 119-32.
20. Floreani A, Zappalà F, Mazzetto M, Naccarato R, Plebani M. Chiaramonte M. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease. Dig Dis Sci 1994; 1: 9-14.
21. Nyberg A, Lindqvist U, Engström-Laurent A. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome. J Intern Med 1992; 231: 485-91.
22. Plebani M, Giacomini A, Floreani A, Chiaramonte M, Soffiati G, Naccarato R, Burlina A. Biochemical markers of hepatic fibrosis in primary biliary cirrhosis. Res Clin Lab 1990; 20: 269-74.
23. Bentsen KD, Horn T, Risteli L, Risteli J, Engström-Laurent A, Hørslev-Petersen K, Lorenzen I. and the Copenhagen study group on fibrotic diseases. Serum aminoterminal type III procollagen peptide and the 7S domain of collagen type IV in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. Liver 1987; 7: 339-46.
24. Henriksen JH, Bentsen KD, Laurent TC. Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease. J Hepatol 1988; 6: 158-66.
25. Kopf J, Gressner AM, Tittor W. Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum. Clin Chem 1991; 37: 30-35.
26. Gibson PR, Fraser JRE, Brown TJ, Finch CF, Jones PA, Coleman JC, Dudley FJ. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology 1992; 6: 1054-9.
27. Gibson PR, Fraser JRE, Colman JC, Jones PA, Jennings G, Dudley FJ. Change in serum hyaluronan: a simple index of short-term drug-induced changes in hepatic sinusoidal perfusion. Gastroenterology 1993; 105: 470-74.
28. Mattsson L, Lindqvist U, Weiland O, Åberg B. Serum levels of aminoterminal propeptide of type III procollagen and hyaluronan during resolving and nonresolving post-transfusion non-A, non-B hepatitis. Scand J Infect Dis 1990; 22: 11-7.
29. Ramadori G, Zöhrens G, Manns M, Rieder H, Dienes P, Hess G. Meyer zum Büschenfelde K-H. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991; 21: 323-30.
30. Guéchot J, Poupon RE, Giral P, Balkau B, Giboudeau J, Poupon R. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 1994; 20: 388-93.
31. Guéchot J, Loria A, Serfaty L, Giral G, Giboudeau J, Poupon R. Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C, effect of α-interferon therapy. J Hepatol 1995; 22: 22-6.
32. Bramley PN, Rathbone BJ, Forbes MA, Cooper EH, Losowsky MS. Serum hyaluronate as a marker of hepatic derangement in acute liver damage. J Hepatol 1991; 13: 8-13.
33. Yokoi Y, Nakamura S, Muro H, Baba S. Functional abnormalities of sinusoidal endothelial cells in rats with acute liver rejection. Transplantation 1994; 57: 27-31.
34. Adams DH, Wang L, Hubscher SC, Neuberger JM. Hepatic endothelial cells. Targets in allograft rejection? Transplantation 1989; 47: 479-82.
35. Pollard SC, Forbes MA, Metcalfe SM, Cooper EH, Calne RY. Hyaluronic acid in the assessment of liver graft function. Transplant Proc 1990; 22: 2301-2.
36. Rao PN, Bronsther OL, Pinna AD, Demetris A, Snyder J, Fung J, Starzl TE. Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation. Transplant Proc 1993; 25: 2141-2.
37. Bronsther OL, Rao PN, Pinna A, Snyder J, Cowan S, Kramer D et al. Effluent levels of hyaluronic acid can predict ultimate graft outcome after clinical liver transplantation: a prospective series. Transplant Proc 1993; 25: 1538-40.